H-1B Filings
11
DOL labor condition applications on file
Boehringer Ingelheim Pharmaceuticals, INC. in CT (Manufacturing) pairs H-1B sponsorship (11 LCAs) with WARN history (1 notice) and has no employer OSHA injury log here.
Boehringer Ingelheim Pharmaceuticals, INC. (CT): · 11 H-1B LCAs at a $164,854 disclosed median · 1 WARN notice
According to DOL OFLC H-1B disclosures, OSHA ITA injury logs, and state WARN Act notices, Boehringer Ingelheim Pharmaceuticals, INC. in CT carries 11 H-1B wage filings on record, a $164,854 median wage (above the $120,000 national median) and 1 WARN layoff notice on file. H-1B filing volume ranks #2,607 of 36,919 sponsors in this corpus (about the 92nd percentile). Every figure is a federal filing, not an estimate; see methodology for coverage limits.
Layoff & federal record
According to U.S. Department of Labor, OSHA, and state WARN Act filings, Boehringer Ingelheim Pharmaceuticals, INC. carries 11 H-1B wage filings on record, a $164,854 median wage (above the $120,000 national median) and 1 WARN layoff notice on file. In this corpus, H-1B filing volume ranks #2,607 of 36,919 sponsors in this corpus (about the 92nd percentile), and disclosed median wage sits at the 79th percentile of 178,031 credible H-1B wage rows.
Figures above come from DOL H-1B LCAs and state WARN notices; no employer OSHA injury log is on file here.
DOL LCA release change
H-1B Filings
11
DOL labor condition applications on file
Median H-1B Salary
$164,854
Across 11 disclosed positions
WARN Workforce Impact
119 workers
1 WARN Act notice on file
Where Boehringer Ingelheim Pharmaceuticals, INC.'s H-1B wage sits nationally
Median disclosed wage vs. all US employers with H-1B filings
$164,854 Top 21% higher than 79% of 178,031 US employers
Each bar is a $20K-wide band; taller bars hold more US employers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source DOL Office of Foreign Labor Certification, H-1B Disclosure Data · August 2026
| Field | Value | Source |
|---|---|---|
| Employer Name | Boehringer Ingelheim Pharmaceuticals, INC. | DOL OFLC / WARN |
| Industry | Manufacturing | NAICS / DOL |
| State | CT | U.S. Federal Records |
| H-1B Filings | 11 | DOL OFLC LCA Disclosure |
| H-1B Median Salary | $164,854 | DOL OFLC LCA Disclosure |
| WARN Layoff Notices | 1 notice(s), 119 workers | WARN Act notices, state workforce agency originals (archival backstop: LayoffData.com) |
| Tracks not on file | employer OSHA injury log | Empty by design, not estimated |
Boehringer Ingelheim Pharmaceuticals, INC.'s values above reflect the most recent DOL Labor Condition Applications, WARN Act notices on file for this employer in CT (Manufacturing). In this corpus, H-1B filing volume ranks #2,607 of 36,919 sponsors in this corpus (about the 92nd percentile); disclosed median wage sits at the 79th percentile of 178,031 credible H-1B wage rows; WARN notice count sits below 3% of 290,575 employers (more notices elsewhere).
| Job Title | Median |
|---|---|
| AD, Patient Data Governance Data Warehouse & Analytics | $180,000 |
| Principal Clinical Data Scientist | $180,000 |
| Principal Scientist, Comp Biology (Expert) | $180,000 |
| ASSOCIATE DIRECTOR, PRINCIPAL CLINICAL DATA SCIENTIST | $169,740 |
| Principal Scientist, Process Research | $167,508 |
| Assoc. Dir., Principal Clinical Data Engineer | $164,854 |
| Assoc. Dir., Principal Clinical Data Engineer | $164,854 |
| Senior Clinical Data Scientist | $155,920 |
| SCIENTIST IV, DRUG METABOLISM & PHARMACOKINETICS | $135,960 |
| Senior Scientist | $130,000 |
| Scientist III | $106,850 |
Boehringer Ingelheim Pharmaceuticals, INC. operating in CT within the Manufacturing sector: the company has filed 11 H-1B labor condition applications, of which 11 disclose a usable wage figure with a median of $164,854. Records here combine U.S. Department of Labor disclosures and state workforce agency filings.
1 WARN Act notice affecting 119 workers has been filed against Boehringer Ingelheim Pharmaceuticals, INC. in CT. Multiple notices can mean consolidations or broader restructuring; weigh them next to this employer's pay and safety signals, and the employer's own disclosures, when judging an offer.
Boehringer Ingelheim Pharmaceuticals, INC. is one of the rarer profiles that carries both sponsorship volume (11 H-1B LCAs) and WARN history (1 notice) in the same public record for Manufacturing in CT. Weigh those two signals separately before treating either as the whole story.
Boehringer Ingelheim Pharmaceuticals, INC.'s nearest H-1B-filing peers in Manufacturing (home state CT). Each card links to that employer's federal-records profile.
| Notice Date | Workers |
|---|---|
| 2016-12-01 | 119 |
What to check before working with Boehringer Ingelheim Pharmaceuticals, INC.
Boehringer Ingelheim Pharmaceuticals, INC. needs a three-way read: H-1B pay (11 LCAs), safety, and WARN history (1 notice); none of those alone is the rating.
Boehringer Ingelheim Pharmaceuticals, INC.'s figures are legally filed public records (DOL, OSHA, state WARN), not reviews or vendor estimates; a missing row is not proof the underlying activity never happened.
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from OSHA and the DOL Wage and Hour Division. Consult a qualified professional before making decisions based on this data.
Learn more: Safety Grades Explained | H-1B Salary Negotiation
Read our methodology - how this data is sourced, computed, and verified.
This profile is rendered directly from DOL H-1B disclosure filings and state WARN Act layoff notices, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.